Eupraxia Pharmaceuticals ... (EPRX)
NASDAQ: EPRX
· Real-Time Price · USD
5.15
-0.08 (-1.53%)
At close: Aug 26, 2025, 11:43 AM
-1.53% (1D)
| Bid | 5.12 |
| Market Cap | 184.97M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -28.96M |
| EPS (ttm) | -0.86 |
| PE Ratio (ttm) | -5.98 |
| Forward PE | -6.1 |
| Analyst | Buy |
| Ask | 5.17 |
| Volume | 3,717 |
| Avg. Volume (20D) | 12,023 |
| Open | 5.16 |
| Previous Close | 5.23 |
| Day's Range | 5.10 - 5.20 |
| 52-Week Range | 2.20 - 6.20 |
| Beta | 1.54 |
About EPRX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol EPRX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for EPRX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 week ago
+1.49%
Eurpraxia Pharmaceuticals shares are trading highe...
Unlock content with
Pro Subscription
6 months ago
+10.37%
Eupraxia Pharmaceuticals shares are trading higher after the company reported its trial data results for eosinophilic esophagitis treatment.